Saori Mishima

Kashiwa, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 78 publications

Clinical practice guidelines for duodenal cancer 2025.

Clinical practice guidelines for duodenal cancer 2025.

Journal: Journal of gastroenterology

Published: July 31, 2026

Circulating Tumor DNA Status and Adjuvant Chemotherapy in Resected Colorectal Liver Metastases.

Circulating Tumor DNA Status and Adjuvant Chemotherapy in Resected Colorectal Liver Metastases.

Journal: JAMA oncology

Published: July 03, 2026

Gastrointestinal perforation associated with bevacizumab and palliative radiotherapy.

Gastrointestinal perforation associated with bevacizumab and palliative radiotherapy.

Journal: International journal of clinical oncology

Published: May 31, 2026

A phase II study of pembrolizumab plus chemotherapy with short-course radiotherapy as induction treatment for unresectable locally advanced esophageal squamous cell carcinoma: PALADIN trial.

A phase II study of pembrolizumab plus chemotherapy with short-course radiotherapy as induction treatment for unresectable locally advanced esophageal squamous cell carcinoma: PALADIN trial.

Journal: ESMO gastrointestinal oncology

Published: May 28, 2026

Impact of claudin 18.2 expression on the efficacy of trastuzumab deruxtecan in patients with HER2-positive gastric or gastroesophageal junction cancer.

Impact of claudin 18.2 expression on the efficacy of trastuzumab deruxtecan in patients with HER2-positive gastric or gastroesophageal junction cancer.

Journal: ESMO gastrointestinal oncology

Published: April 17, 2026

Molecular Residual Disease and Recurrence in Rectal Cancer Patients Undergoing Upfront Surgery A Prospective Cohort Study: Erratum.

Molecular Residual Disease and Recurrence in Rectal Cancer Patients Undergoing Upfront Surgery A Prospective Cohort Study: Erratum.

Journal: Annals of surgery

Published: April 09, 2026

Clinical significance of WES-defined ERBB2 amplification in resectable colorectal cancer.

Clinical significance of WES-defined ERBB2 amplification in resectable colorectal cancer.

Journal: International journal of clinical oncology

Published: April 08, 2026

Trifluridine/tipiracil with or without bevacizumab in microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: A retrospective observational study.

Trifluridine/tipiracil with or without bevacizumab in microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: A retrospective observational study.

Journal: Therapeutic advances in medical oncology

Published: March 21, 2026

Temporal dynamics of CLDN18.2 expression following zolbetuximab treatment in advanced gastric cancer.

Temporal dynamics of CLDN18.2 expression following zolbetuximab treatment in advanced gastric cancer.

Journal: ESMO gastrointestinal oncology

Published: February 06, 2026

Durable Complete Response and Potential Cure With Systemic Chemotherapy in Metastatic Gastric Cancer: A Case Series of Patients.

Durable Complete Response and Potential Cure With Systemic Chemotherapy in Metastatic Gastric Cancer: A Case Series of Patients.

Journal: JCO oncology practice

Published: December 19, 2025

Preoperative ctDNA and tumor volume predict colorectal cancer recurrence after metastasis resection.

Preoperative ctDNA and tumor volume predict colorectal cancer recurrence after metastasis resection.

Journal: NPJ precision oncology

Published: October 22, 2025

Prognostic significance of the neutrophil-to-lymphocyte ratio in esophageal squamous cell carcinoma treated with proton beam therapy.

Prognostic significance of the neutrophil-to-lymphocyte ratio in esophageal squamous cell carcinoma treated with proton beam therapy.

Journal: Radiation oncology journal

Published: September 28, 2025

Showing 1-12 of 78

Last Updated: 09/26/2026